IL159558A0 - Use of il-6 in liver injury - Google Patents

Use of il-6 in liver injury

Info

Publication number
IL159558A0
IL159558A0 IL15955803A IL15955803A IL159558A0 IL 159558 A0 IL159558 A0 IL 159558A0 IL 15955803 A IL15955803 A IL 15955803A IL 15955803 A IL15955803 A IL 15955803A IL 159558 A0 IL159558 A0 IL 159558A0
Authority
IL
Israel
Prior art keywords
liver injury
liver
injury
Prior art date
Application number
IL15955803A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Priority to IL15955803A priority Critical patent/IL159558A0/xx
Publication of IL159558A0 publication Critical patent/IL159558A0/xx
Priority to EP04806689.8A priority patent/EP1744777B1/en
Priority to JP2006546474A priority patent/JP2007517018A/ja
Priority to CA002551504A priority patent/CA2551504A1/en
Priority to PCT/IL2004/001158 priority patent/WO2005060990A2/en
Priority to AU2004305337A priority patent/AU2004305337A1/en
Priority to US10/583,370 priority patent/US7799322B2/en
Priority to ES04806689.8T priority patent/ES2493391T3/es
Priority to IL176325A priority patent/IL176325A/en
Priority to NO20063412A priority patent/NO20063412L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
IL15955803A 2003-12-24 2003-12-24 Use of il-6 in liver injury IL159558A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL15955803A IL159558A0 (en) 2003-12-24 2003-12-24 Use of il-6 in liver injury
EP04806689.8A EP1744777B1 (en) 2003-12-24 2004-12-23 Use of il-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury
JP2006546474A JP2007517018A (ja) 2003-12-24 2004-12-23 肝臓傷害におけるｉｌ−６の使用
CA002551504A CA2551504A1 (en) 2003-12-24 2004-12-23 Use of il-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury
PCT/IL2004/001158 WO2005060990A2 (en) 2003-12-24 2004-12-23 Use of il-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury
AU2004305337A AU2004305337A1 (en) 2003-12-24 2004-12-23 Use of IL-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury
US10/583,370 US7799322B2 (en) 2003-12-24 2004-12-23 Use of IL-6 in liver injury
ES04806689.8T ES2493391T3 (es) 2003-12-24 2004-12-23 Uso de IL-6 en la preparación de composiciones farmacéuticas para tratar y prevenir lesiones hepáticas
IL176325A IL176325A (en) 2003-12-24 2006-06-15 Use of 6 il in the preparation of pharmaceutical preparations for the treatment and prevention of liver injury
NO20063412A NO20063412L (no) 2003-12-24 2006-07-24 Anvendelse av IL-6 ved leverskade

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15955803A IL159558A0 (en) 2003-12-24 2003-12-24 Use of il-6 in liver injury

Publications (1)

Publication Number Publication Date
IL159558A0 true IL159558A0 (en) 2004-06-01

Family

ID=33485367

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15955803A IL159558A0 (en) 2003-12-24 2003-12-24 Use of il-6 in liver injury
IL176325A IL176325A (en) 2003-12-24 2006-06-15 Use of 6 il in the preparation of pharmaceutical preparations for the treatment and prevention of liver injury

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL176325A IL176325A (en) 2003-12-24 2006-06-15 Use of 6 il in the preparation of pharmaceutical preparations for the treatment and prevention of liver injury

Country Status (9)

Country Link
US (1) US7799322B2 (xx)
EP (1) EP1744777B1 (xx)
JP (1) JP2007517018A (xx)
AU (1) AU2004305337A1 (xx)
CA (1) CA2551504A1 (xx)
ES (1) ES2493391T3 (xx)
IL (2) IL159558A0 (xx)
NO (1) NO20063412L (xx)
WO (1) WO2005060990A2 (xx)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04218000A (ja) * 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
JPH05178756A (ja) * 1991-12-26 1993-07-20 Toray Ind Inc 肝疾患の予防・治療薬
IL122818A0 (en) 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
US5919763A (en) * 1998-06-01 1999-07-06 Hadasit Medical Research Services And Development Company Ltd. IL-6/SIL-6R complex for promotion of liver functions
AU782496B2 (en) * 1999-07-13 2005-08-04 Bolder Biotechnology, Inc. Immunoglobulin fusion proteins

Also Published As

Publication number Publication date
JP2007517018A (ja) 2007-06-28
WO2005060990A3 (en) 2005-08-11
ES2493391T3 (es) 2014-09-11
EP1744777A2 (en) 2007-01-24
WO2005060990A2 (en) 2005-07-07
CA2551504A1 (en) 2005-07-07
NO20063412L (no) 2006-07-24
EP1744777B1 (en) 2014-05-21
AU2004305337A1 (en) 2005-07-07
US7799322B2 (en) 2010-09-21
US20080025945A1 (en) 2008-01-31
IL176325A0 (en) 2006-10-05
IL176325A (en) 2013-08-29

Similar Documents

Publication Publication Date Title
IL172316A0 (en) Novel compounds and their use in therapy
GB0411940D0 (en) Methods and compositions
EP1701725A4 (en) PROCESS AND COMPOSITIONS
GB0324761D0 (en) Use of compounds in therapy
ZA200600025B (en) Methods and compositions for interferon therapy
EP1633749A4 (en) DEAZAFLAVIN COMPOUNDS AND METHODS OF USE
EP1625141A4 (en) GRP94-BASED COMPOSITIONS AND METHODS OF USE THEREOF
GB0300805D0 (en) Compounds and their use
GB0300804D0 (en) Compounds and their use
GB0327050D0 (en) Therapeutic methods compositions and uses
IL159558A0 (en) Use of il-6 in liver injury
GB0301143D0 (en) Compounds and their use
GB0312844D0 (en) Use of compounds in medicine
GB0303165D0 (en) Therapeutic methods and compositions for use therein
GB0310251D0 (en) Therapeutic methods and compositions for use therein
GB0326870D0 (en) Therapeutic methods and compositions for use therein
GB0302801D0 (en) Therapeutic methods and compositions for use therein
GB0407993D0 (en) Therapeutic methods and compositions for use therein
GB0418363D0 (en) Therapeutic methods and compositions for use therein
GB0306444D0 (en) Composition and its therapeutic use
GB0330062D0 (en) Compositions and methods
HU0800174D0 (en) Biohouse and accessories for this
GB0302930D0 (en) Compounds and their use
GB0316203D0 (en) Compounds and their use
GB0310472D0 (en) Compounds and their use